Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01479244 |
Title | Efficacy and Safety Study of NeuVax (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence |
Acronym | PRESENT |
Recruitment | Completed |
Gender | female |
Phase | Phase III |
Variant Requirements | No |
Sponsors | Galena Biopharma, Inc. |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA | ROU | POL | ISR | HUN | GBR | FRA | DEU | CAN | BGR |